Tyra Biosciences, Inc. TYRA Other accrued liabilities
Other accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s other accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s other accrued liabilities?
- Tyra Biosciences, Inc. (TYRA) reported other accrued liabilities of $15.13M in Q1 2026.
- How has Tyra Biosciences, Inc.'s other accrued liabilities changed year-over-year?
- Tyra Biosciences, Inc.'s other accrued liabilities increased by 33.6% year-over-year, from $11.32M to $15.13M.
- What is the long-term trend for Tyra Biosciences, Inc.'s other accrued liabilities?
- Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s other accrued liabilities has grown at a 73.3% compound annual growth rate (CAGR), from $1.05M to $16.44M.